Drug Pipeline

Clotting factor concentrates (CFC) or bypassing agents (BPA) Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
2
Recruiting
2
Phase 3
1
Top Sponsors
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-05-27 NCT07285460
A Study to Investigate the Efficacy and Safety of Fitusiran Prophylaxis in Male…		 Trial sites expanded: 24 -> 27 locations
Active Studies by Phase
Phase 4
1
Phase 3
2
Active Trials
NCT IDTitleConditionStatus
Phase 4
NCT06145373 A Study to Test a Medicine (Fitusiran) for Preventing Bleeds in People With Severe… Hemophilia A Recruiting
Phase 3
NCT07285460 A Study to Investigate the Efficacy and Safety of Fitusiran Prophylaxis in Male… Hemophilia Recruiting
NCT05662319 A Study to Test a Medicine (Fitusiran) Injected Under the Skin for Preventing Bleeding… Hemophilia Active, Not Recruiting
Sponsors Running Clotting factor concentrates (CFC) or bypassing agents (BPA) Trials
Sanofi (3)
Disease Areas
Hemophilia (3)
Get alerts when Clotting factor concentrates (CFC) or bypassing agents (BPA) trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free